Israel’s Pluristem Therapeutics’s placenta-based cell therapy (see here) could be used to treat patients suffering from respiratory and inflammatory complications associated with coronavirus. Pluristem has launched a joint project with two Berlin-based medical institutions.
https://unitedwithisrael.org/novel-israeli-therapy-takes-aim-at-coronavirus/